Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study-0

Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: The population-based Tromsø Study 1994-2016

Langholz, Petja Lyn
Wilsgaard, Tom
Njølstad, Inger
Jorde, Rolf
Hopstock, Laila Arnesdatter

January 2021

Objectives - The aim of this study was to investigate time trends in known and undiagnosed diabetes,...

Diabetes Care

CC999999/Intramural CDC HHS/United States2019-05-09T00:00:00Z30894387PMC65080666242vault:3212

Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: real-world evidence from primary care.

Joanna ZJ Ling (10490918)
Olga Montvida (8881132)
Kamlesh Khunti (171607)
Anthony L Zhang (10490921)
Charlie C Xue (10490924)
Sanjoy K Paul (9525931)

March 2021

ObjectiveTo investigate trends in the prevalence of hypertension and dyslipidaemia in incident type ...

Trends in percentages of patients with elevated blood pressure levels and subsequent treatment modifications (1998–2004)

Jacoba P Greving (80603)
Petra Denig (80604)
Dick de Zeeuw (80605)
Henk JG Bilo (80606)
Flora M Haaijer-Ruskamp (80607)

December 2011

Copyright information:Taken from "Trends in hyperlipidemia and hypertension managem...

Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study

Greving, Jacoba P.
Denig, Petra
de Zeeuw, Dick
Bilo, Henk J. G.
Haaijer-Ruskamp, Flora M.

September 2007

Background: Lack of treatment initiation or intensification might explain why some patients with typ...

Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004:a longitudinal observational study

Greving, Jacoba P.
Denig, Petra
de Zeeuw, Dick
Bilo, Henk J. G.
Haaijer-Ruskamp, Flora M.

September 2007

Background: Lack of treatment initiation or intensification might explain why some patients with typ...

CARDIOLOGY ®Original scientific paper Change in cardiovascular risk factors in relation to diabetes status: the Tromsø Study

Society O F
Josepha Joseph
Johan Svartberg
Inger Njølstad
Henrik Schirmer

January 2010

Aims: To investigate changes in cardiovascular risk factors over 14 years in relation to diabetes st...

Temporal trends in co‐morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK

Joanna Ling (8881110)
Digsu Koye (5516330)
Luke Buizen (10175440)
Kamlesh Khunti (171607)
Olga Montvida (8881132)
Sanjoy K Paul (9525931)

January 2021

AimTo evaluate temporal patterns in co‐morbidities, cardiometabolic risk factors and a high atherosc...

Trends in vascular risk factors and medication use in patients with various manifestations of vascular diseases or type 2 diabetes mellitus from 1996 to 2007: the Second Manifestations of Arterial Disease (SMART) Study

Vlek, A.L.M.
Visseren, F.L.J.
Algra, A.
Soedamah-Muthu, S.S.
Moll, F.L.
Doevendans, P.A.
Kappelle, L.J.
Graaf, Y., van der

January 2010

Aims: To investigate time trends in vascular risk factors and medication use for patients referred t...

Treatment of cardiovascular risk factors in type 2 diabetes : time trends and clinical practice

Fhärm, Eva

January 2010

Objectives Patients with type 2 diabetes are at much greater risk of developing cardiovascular disea...

Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status.

Wong, Nathan D
Patao, Christopher
Wong, Kalina
Malik, Shaista
Franklin, Stanley S
Iloeje, Uchenna

November 2013

BackgroundMost patients with type 2 diabetes mellitus (T2DM) suffer from cardiovascular disease (CVD...

Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes." Diabetes Care 26(6

Fredric J. Cohen
Cheryl A. Neslusan
Jonathan E. Conklin
Xue Song Phd

January 2003

OBJECTIVE — The mid-1990s witnessed the introduction of new classes of medications to treat hypergly...

Trends in Cardiovascular Disease Risk Factors in People with and without Diabetes Mellitus: A Middle Eastern Cohort Study

Younes Jahangiri-Noudeh (668064)
Samaneh Akbarpour (668065)
Mojtaba Lotfaliany (463808)
Neda Zafari (668066)
Davood Khalili (305371)
Maryam Tohidi (305368)
Mohammad Ali Mansournia (635074)
Fereidoun Azizi (305375)
Farzad Hadaegh (305376)

December 2014

<div>Aims/HypothesisTo investigate secular trends in cardiovascular disease (CVD) risk fac...

Linear trends over timea in lipid profile and glycemic levels among US adults aged ≥21 years by diabetesb and cholesterol medication usec—National Health and Nutrition Examination Survey, 2003–2012.

Carla I. Mercado (4915612)
Edward Gregg (3485237)
Cathleen Gillespie (469162)
Fleetwood Loustalot (469163)

March 2018

Linear trends over time<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0193...

Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: the population-based Tromsø Study 1994–2016

Laila Arnesdatter Hopstock
Inger Njølstad
Petja Lyn Langholz
Rolf Jorde

March 2021

Objectives The aim of this study was to investigate time trends in known and undiagnosed diabetes, g...

Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: The population-based Tromsø Study 1994-2016

Langholz, Petja Lyn
Wilsgaard, Tom
Njølstad, Inger
Jorde, Rolf
Hopstock, Laila Arnesdatter

January 2021

Objectives - The aim of this study was to investigate time trends in known and undiagnosed diabetes,...

Diabetes Care

CC999999/Intramural CDC HHS/United States2019-05-09T00:00:00Z30894387PMC65080666242vault:3212

Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: real-world evidence from primary care.

Joanna ZJ Ling (10490918)
Olga Montvida (8881132)
Kamlesh Khunti (171607)
Anthony L Zhang (10490921)
Charlie C Xue (10490924)
Sanjoy K Paul (9525931)

March 2021

ObjectiveTo investigate trends in the prevalence of hypertension and dyslipidaemia in incident type ...

Trends in percentages of patients with elevated blood pressure levels and subsequent treatment modifications (1998–2004)

Jacoba P Greving (80603)
Petra Denig (80604)
Dick de Zeeuw (80605)
Henk JG Bilo (80606)
Flora M Haaijer-Ruskamp (80607)

December 2011

Copyright information:Taken from "Trends in hyperlipidemia and hypertension managem...

Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study

Greving, Jacoba P.
Denig, Petra
de Zeeuw, Dick
Bilo, Henk J. G.
Haaijer-Ruskamp, Flora M.

September 2007

Background: Lack of treatment initiation or intensification might explain why some patients with typ...

Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004:a longitudinal observational study

Greving, Jacoba P.
Denig, Petra
de Zeeuw, Dick
Bilo, Henk J. G.
Haaijer-Ruskamp, Flora M.

September 2007

Background: Lack of treatment initiation or intensification might explain why some patients with typ...

CARDIOLOGY ®Original scientific paper Change in cardiovascular risk factors in relation to diabetes status: the Tromsø Study

Society O F
Josepha Joseph
Johan Svartberg
Inger Njølstad
Henrik Schirmer

January 2010

Aims: To investigate changes in cardiovascular risk factors over 14 years in relation to diabetes st...

Temporal trends in co‐morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK

Joanna Ling (8881110)
Digsu Koye (5516330)
Luke Buizen (10175440)
Kamlesh Khunti (171607)
Olga Montvida (8881132)
Sanjoy K Paul (9525931)

January 2021

AimTo evaluate temporal patterns in co‐morbidities, cardiometabolic risk factors and a high atherosc...

Trends in vascular risk factors and medication use in patients with various manifestations of vascular diseases or type 2 diabetes mellitus from 1996 to 2007: the Second Manifestations of Arterial Disease (SMART) Study

Vlek, A.L.M.
Visseren, F.L.J.
Algra, A.
Soedamah-Muthu, S.S.
Moll, F.L.
Doevendans, P.A.
Kappelle, L.J.
Graaf, Y., van der

January 2010

Aims: To investigate time trends in vascular risk factors and medication use for patients referred t...

Treatment of cardiovascular risk factors in type 2 diabetes : time trends and clinical practice

Fhärm, Eva

January 2010

Objectives Patients with type 2 diabetes are at much greater risk of developing cardiovascular disea...

Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status.

Wong, Nathan D
Patao, Christopher
Wong, Kalina
Malik, Shaista
Franklin, Stanley S
Iloeje, Uchenna

November 2013

BackgroundMost patients with type 2 diabetes mellitus (T2DM) suffer from cardiovascular disease (CVD...

Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes." Diabetes Care 26(6

Fredric J. Cohen
Cheryl A. Neslusan
Jonathan E. Conklin
Xue Song Phd

January 2003

OBJECTIVE — The mid-1990s witnessed the introduction of new classes of medications to treat hypergly...

Trends in Cardiovascular Disease Risk Factors in People with and without Diabetes Mellitus: A Middle Eastern Cohort Study

Younes Jahangiri-Noudeh (668064)
Samaneh Akbarpour (668065)
Mojtaba Lotfaliany (463808)
Neda Zafari (668066)
Davood Khalili (305371)
Maryam Tohidi (305368)
Mohammad Ali Mansournia (635074)
Fereidoun Azizi (305375)
Farzad Hadaegh (305376)

December 2014

<div>Aims/HypothesisTo investigate secular trends in cardiovascular disease (CVD) risk fac...

Linear trends over timea in lipid profile and glycemic levels among US adults aged ≥21 years by diabetesb and cholesterol medication usec—National Health and Nutrition Examination Survey, 2003–2012.

Carla I. Mercado (4915612)
Edward Gregg (3485237)
Cathleen Gillespie (469162)
Fleetwood Loustalot (469163)

March 2018

Linear trends over time<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0193...

Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: the population-based Tromsø Study 1994–2016

Laila Arnesdatter Hopstock
Inger Njølstad
Petja Lyn Langholz
Rolf Jorde

March 2021

Objectives The aim of this study was to investigate time trends in known and undiagnosed diabetes, g...

Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: The population-based Tromsø Study 1994-2016

Langholz, Petja Lyn
Wilsgaard, Tom
Njølstad, Inger
Jorde, Rolf
Hopstock, Laila Arnesdatter

January 2021

Objectives - The aim of this study was to investigate time trends in known and undiagnosed diabetes,...

Diabetes Care

CC999999/Intramural CDC HHS/United States2019-05-09T00:00:00Z30894387PMC65080666242vault:3212

Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: real-world evidence from primary care.

Joanna ZJ Ling (10490918)
Olga Montvida (8881132)
Kamlesh Khunti (171607)
Anthony L Zhang (10490921)
Charlie C Xue (10490924)
Sanjoy K Paul (9525931)

March 2021

ObjectiveTo investigate trends in the prevalence of hypertension and dyslipidaemia in incident type ...

Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study-0

Abstract

Extracted data

Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study-0

Abstract

Extracted data

Related items

Related items